Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

MediLink Therapeutics and Roche Establish Worldwide Partnership and License Agreement for the Development of Advanced Oncology Antibody Drug Conjugate

Wednesday, January 03, 2024

MediLink Therapeutics also known as MediLink has recently disclosed a global collaboration and licensing agreement with Roche for the development of a new antibodydrug conjugate candidate

CGBio's 'NOVOSIS PUTTY' Attains FDA 'Breakthrough Device Designation,' Paving the Way for Expedited Entry into the US Market

Wednesday, January 03, 2024

CGBio under the leadership of CEO Hyun Seung Yu a South Korean bioregenerative medicine company announced on the nd that its advanced bone substitute material NOVOSIS PUTTY has received

Beyfortus Granted Approval in China for Preventing RSV Disease in Infants

Tuesday, January 02, 2024

AstraZeneca and Sanofi have obtained approval from Chinas National Medical Products Administration NMPA for their longacting monoclonal antibody Beyfortus as a preventive measure against respiratory syncytial virus

Positive Outcomes Revealed in Interim Analysis of REC610, Recbio's Innovative Adjuvanted Recombinant Shingles Vaccine Clinical Trial in the Philippines

Friday, December 29, 2023

Jiangsu Recbio Technology Co Ltd is thrilled to report positive results from the interim analysis of the firstinhuman clinical trial conducted in the Philippines for its novel adjuvanted recombinant shingles vaccine

Innovent and Xuanzhu Partner on Sintilimab Combination Trial for Advanced Solid Tumors in China

Thursday, December 28, 2023

Innovent Biologics Inc and Xuanzhu Biopharma have recently disclosed a partnership involving a clinical trial and supply agreement for exploring combination therapies of sintilimab injection

Biocytogen and CtM Bio Make Noteworthy Progress in Collaborative Development of TCR-Mimic Antibody-Based Multi-Specific T Cell Engager Targeting WT1/HLA-A02

Thursday, December 28, 2023

Biocytogen Pharmaceuticals Co Ltd and CtM Biotech Co Ltd have reported significant advancements in the development of a trispecific T cell engager targeting an intracellular protein

Everest Medicines Has Received Approval for the New Drug Application (NDA) for Nefecon® in Taiwan, Aimed at Treating Primary IGA Nephropathy in Adult Patients

Wednesday, December 27, 2023

Everest Medicines has declared that the Taiwan Food and Drug Administration has accepted its New Drug Application for Nefecon for the treatment of primary immunoglobulin A nephropathy

LianBio Enters into an Agreement Transferring Rights for NBTXR3 in China and Other Asian Markets

Tuesday, December 26, 2023

LianBio a biotechnology company dedicated to introducing innovative medicines to patients in China and other significant Asian markets has announced a recent agreement with Janssen Pharmaceutica NV

FDA Approves Label Revision for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)

Saturday, December 23, 2023

BeiGene Ltd has received approval from the US Food and Drug Administration for a label update for BRUKINSA zanubrutinib This update is based on superior progressionfree survival

CStone Transfers Its Exclusive Rights for TIBSOVO® to Servier in Greater China and Singapore

Friday, December 22, 2023

CStone Pharmaceuticals and Servier a global pharmaceutical group have recently announced a collaborative agreement This agreement entails Servier acquiring exclusive rights to develop